Status:
UNKNOWN
A Multicenter Clinical Trial: Efficacy, Safety of Fecal Microbiota Transplantation for Inflammatory Bowel Disease
Lead Sponsor:
Zhongshan Hospital Xiamen University
Conditions:
Inflammatory Bowel Disease, Ulcerative Colitis Type
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
There are many limitations in the current treatments of Inflammatory bowel disease(IBD). Some patients have no or little reaction to the traditional drugs. Now the investigators realized that the inte...
Detailed Description
In this projects the investigators aim to re-establish a gut balance of intestinal microbiota through Standardized Fecal Microbiota Transplantation for IBD (UC and CD). We have established a standardi...
Eligibility Criteria
Inclusion
- Standard or conventional medicine treatment ineffective of IBD patients
- IBD patients with recurrent symptoms
- IBD patients who had drug dependence or recurrence when reduced or discontinued use
- Untreated IBD patients who voluntarily received FMT
Exclusion
- IBD patients with contraindications for gastrointestinal endoscopy
- IBD patients combined with other serious diseases such as respiratory failure, heart failure and severe immunodeficiency
- IBD patients with indication of surgery
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04521205
Start Date
December 1 2020
End Date
April 30 2024
Last Update
November 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yanyun Fan
Xiamen, China